Validity of multiplex-based assays for cytokine measurements in serum and plasma from “non-diseased” subjects: Comparison with ELISA

Multiplex-based immunoassays (MIA) allow the simultaneous measurement of different cytokines in small sample volumes, but their applicability in samples from “healthy” subjects, as those participating in large-scale epidemiological studies is not well known. We compared measurements of interleukin-6...

Full description

Saved in:
Bibliographic Details
Published inJournal of immunological methods Vol. 350; no. 1; pp. 125 - 132
Main Authors Dossus, Laure, Becker, Susen, Achaintre, David, Kaaks, Rudolf, Rinaldi, Sabina
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 31.10.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Multiplex-based immunoassays (MIA) allow the simultaneous measurement of different cytokines in small sample volumes, but their applicability in samples from “healthy” subjects, as those participating in large-scale epidemiological studies is not well known. We compared measurements of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-1 receptor antagonist (IL-1Ra), C-reactive protein (CRP) and soluble CD40L (sCD40L) obtained by MIA with those obtained by enzyme-linked immunosorbent assays (ELISA) in serum and plasma samples from 36 “healthy” subjects. We observed good correlations between measurements obtained by MIA and ELISA for IL-1Ra, CRP and sCD40L ( r > 0.80) but poor correlations for IL-6, TNF-α and IL-1β ( r < 0.40). When comparing MIA plasma and serum measurements, very high correlations were obtained for CRP ( r = 0.98) and fairly good correlations for IL-1Ra ( r = 0.60). In conclusion, multiplex-based assays can give an accurate estimate of the relative risk in large-scale epidemiological studies but only for cytokines that are present in relatively large concentrations (ng/mL).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0022-1759
1872-7905
1872-7905
DOI:10.1016/j.jim.2009.09.001